ARX vs NOX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

57MEDIUM

NOX

NOXOPHARM FPO [NOX]

55MEDIUM

Score Breakdown

ARX NOX
Technical
38
46
Catalyst
50
50
Sentiment
50
50
Fundamental
95
39
Momentum
55
60
Risk Gate
50
46

Key Metrics

ARX Metric NOX
$202.9MMarket Cap$26.1M
314KAvg Volume (20d)168K
N/AShort InterestN/A
$0.80052-Week High$0.135
$0.49552-Week Low$0.046
-0.8%Daily Change+4.7%
$0.580Reference Price$0.089
+4.9%ROE-343.6%
+4.5%Profit Margin-161.7%

Active Signals

ARX Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Above-average volume (1.6x) on a red day — sellers in control
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 3.3% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (2.0x)

NOX Signals

●MACD momentum is losing steam
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Drifting lower — down 6.8% over the last 5 days
●Beating the Small Ords index — relative strength of 1.26, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (0.1 quarters)
●Moderate P/S ratio (7.7x)
●Strong revenue growth (+50%)

Ask Scout AI to compare ARX and NOX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ARX vs NYR →ARX vs PAR →ARX vs SPL →ATH vs EIQ →ATH vs ENP →
ARX Full Analysis → NOX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).